These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30648067)

  • 1. Adenocarcinoma of the Lung with Miliary Metastases and Primary Resistance Exon 20 Mutations.
    Hsu F
    Cureus; 2018 Oct; 10(10):e3533. PubMed ID: 30648067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lung Adenocarcinomas with Pulmonary Miliary Metastases: A Case Report and Literature Review].
    Li L; Zhou L; Zhang J
    Zhongguo Fei Ai Za Zhi; 2019 Dec; 22(12):798-804. PubMed ID: 31874677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Miliary brain metastases from lung adenocarcinoma with EGFR (L858R) and CTNNB1 mutations.
    Kunishige M; Takeuchi E
    Thorac Cancer; 2023 Dec; 14(34):3419-3420. PubMed ID: 37920971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Miliary metastases are associated with epidermal growth factor receptor mutations in non-small cell lung cancer: a population-based study.
    Hsu F; Nichol A; Toriumi T; De Caluwe A
    Acta Oncol; 2017 Sep; 56(9):1175-1180. PubMed ID: 28521651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung Adenocarcinoma with Pulmonary Miliary Metastases and Complex Somatic Heterozygous EGFR Mutation.
    Schaller A; Beau-Faller M; Mennecier B; Renaud-Picard B; Weingertner N; Massard G; Quoix E
    Case Rep Oncol; 2014; 7(3):769-73. PubMed ID: 25722667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of diffuse, random pulmonary metastases, including miliary metastases, with epidermal growth factor receptor mutations in lung adenocarcinoma.
    Togashi Y; Masago K; Kubo T; Sakamori Y; Kim YH; Hatachi Y; Fukuhara A; Mio T; Togashi K; Mishima M
    Cancer; 2011 Feb; 117(4):819-25. PubMed ID: 20886633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine kinase inhibitors for epidermal growth factor receptor gene mutation-positive non-small cell lung cancers: an update for recent advances in therapeutics.
    Chung C
    J Oncol Pharm Pract; 2016 Jun; 22(3):461-76. PubMed ID: 25855240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Miliary cerebral carcinomatosis secondary to EGFR mutation-positive lung adenocarcinoma].
    Dumoulin J; Rozensztajn N; Paradis M; Sellier J; Abel A; Giraud P; Labrune S; Chinet T
    Rev Mal Respir; 2016 Jan; 33(1):67-71. PubMed ID: 25794997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Brain Metastases of Non-Small Cell Lung Carcinoma.
    Rybarczyk-Kasiuchnicz A; Ramlau R; Stencel K
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival analysis and pathological features of advanced non-small cell lung cancer with miliary pulmonary metastases in patients harboring epidermal growth factor receptor mutations.
    Okuma Y; Kashima J; Watanabe K; Homma S
    J Cancer Res Clin Oncol; 2018 Aug; 144(8):1601-1611. PubMed ID: 29858682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Impacts of EGFR 19 exon mutations on brain metastases in treatment-naïve patients with lung adenocarcinoma].
    Wang WL; Li HW; Cao JZ; Zhang XQ; Song X; Jia SF; Jia HX
    Zhonghua Zhong Liu Za Zhi; 2017 Oct; 39(10):744-748. PubMed ID: 29061017
    [No Abstract]   [Full Text] [Related]  

  • 12. A lung adenocarcinoma patient with co-mutations of MET and EGFR exon20 insertion responded to crizotinib.
    Chen Y; Jiang B; He Y; Zhang C; Zhou W; Fang C; Gu D; Zhang M; Ji M; Shi J; Yang X
    BMC Med Genomics; 2022 Jun; 15(1):141. PubMed ID: 35739536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Miliary lung metastases from non-small cell lung cancer with Exon 20 insertion: A dismal prognostic entity: A case report.
    Sekine A; Katano T; Oda T; Ikeda S; Iwasawa T; Satoh H; Kataoka T; Okudela K; Ogura T
    Mol Clin Oncol; 2018 Dec; 9(6):673-676. PubMed ID: 30546900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Miliary never-smoking adenocarcinoma of the lung: strong association with epidermal growth factor receptor exon 19 deletion.
    Laack E; Simon R; Regier M; Andritzky B; Tennstedt P; Habermann C; Verth CZ; Thöm I; Grob T; Sauter G; Bokemeyer C
    J Thorac Oncol; 2011 Jan; 6(1):199-202. PubMed ID: 21178715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging Pattern of Diffuse Intrapulmonary Metastases in Lung Cancer Was Associated with Poor Prognosis to Epidermal Growth Factor Receptor Inhibitors.
    Fu Y; Tang Y; Zheng Y; Chen YY; Hong Y; Wang PP; Li Q; Liu T; Ding ZY
    Cancer Manag Res; 2020; 12():11761-11772. PubMed ID: 33235504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features of lung adenocarcinomas with epidermal growth factor receptor mutations and miliary disseminated carcinomatosis.
    Kim HJ; Kang SH; Chung HW; Lee JS; Kim SJ; Yoo KH; Lee KY
    Thorac Cancer; 2015 Sep; 6(5):629-35. PubMed ID: 26445612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic brain tumors from non-small cell lung cancer with EGFR mutations: distinguishing influence of exon 19 deletion on radiographic features.
    Sekine A; Kato T; Hagiwara E; Shinohara T; Komagata T; Iwasawa T; Satoh H; Tamura K; Kasamatsu T; Hayashihara K; Saito T; Takahashi H; Ogura T
    Lung Cancer; 2012 Jul; 77(1):64-9. PubMed ID: 22335887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Effect of First-line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI) Combined with Whole Brain Radiotherapy on Patients with EGFR Mutation-positive Lung Adenocarcinoma and Brain Metastases.
    Ke SB; Qiu H; Chen JM; Shi W; Chen YS
    Curr Med Sci; 2018 Dec; 38(6):1062-1068. PubMed ID: 30536070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR exon 20 insertion mutations in lung adenocarcinomas: prevalence, molecular heterogeneity, and clinicopathologic characteristics.
    Arcila ME; Nafa K; Chaft JE; Rekhtman N; Lau C; Reva BA; Zakowski MF; Kris MG; Ladanyi M
    Mol Cancer Ther; 2013 Feb; 12(2):220-9. PubMed ID: 23371856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitive detection of EGFR mutations in cerebrospinal fluid from lung adenocarcinoma patients with brain metastases.
    Yang H; Cai L; Zhang Y; Tan H; Deng Q; Zhao M; Xu X
    J Mol Diagn; 2014 Sep; 16(5):558-563. PubMed ID: 24994671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.